Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Osteoporosis

Free Subscription 04.11.2019 1 Clin Orthop Relat Res 1 J Bone Miner Res 7 J Clin Endocrinol Metab 4 Osteoporos Int

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Clin Orthop Relat Res

1. GUTIERREZ S
   CORR Insights(R): What Regions of the Distal Clavicle Have the Greatest Bone Mineral Density and Cortical Thickness? A Cadaveric Study.
   Clin Orthop Relat Res. 2019 Oct 23. doi: 10.1097/CORR.0000000000001021.
   PubMed     Text format    
   
   

   
   J Bone Miner Res

2. WONG AK, Chandrakumar A, Whyte R, Reitsma S, et al
   Bone Marrow and Muscle Fat Infiltration are Correlated Among Postmenopausal Women with Osteoporosis: the AMBERS Cohort Study.
   J Bone Miner Res. 2019 Nov 1. doi: 10.1002/jbmr.3910.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Endocrinol Metab

3. GEUSENS P, Marin F, Kendler DL
   Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
   J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606939. doi: 10.1210.
   PubMed     Text format    
   
   
4. LYU H, Zhao SS, Solomon DH
   Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
   J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606941. doi: 10.1210.
   PubMed     Text format    
   
   
5. LI GH, Robinson-Cohen C, Sahni S, Au PC, et al
   Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density.
   J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606940. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
6. KENDLER D, Chines A, Clark P, Ebeling PR, et al
   Bone Mineral Density After Transitioning From Denosumab to Alendronate.
   J Clin Endocrinol Metab. 2019 Oct 26. pii: 5607536. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
7. RAMCHAND SK, David NL, Leder BZ, Tsai JN, et al
   Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.
   J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610890. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   
8. ANAGNOSTIS P, Kenanidis E, Potoupnis M, Tsiridis E, et al
   Letter to the Editor: "Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline."
   J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607923. doi: 10.1210.
   PubMed     Text format    
   
   
9. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
   Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
   J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610884. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   

   
   Osteoporos Int

10. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2019 Oct 31. pii: 10.1007/s00198-019-05184.
    PubMed     Text format     Abstract available
    
    
11. HALLIT S, El Hage C, Hajj A, Salameh P, et al
    Construction and validation of the Lebanese Osteoporosis Knowledge Scale among a representative sample of Lebanese women.
    Osteoporos Int. 2019 Oct 30. pii: 10.1007/s00198-019-05192.
    PubMed     Text format     Abstract available
    
    
12. ALARKAWI D, Bliuc D, Tran T, Ahmed LA, et al
    Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromso Study.
    Osteoporos Int. 2019 Oct 26. pii: 10.1007/s00198-019-05174.
    PubMed     Text format     Abstract available
    
    
13. SOGAARD AJ, Magnus JH, Bjornerem A, Holvik K, et al
    Grip strength in men and women aged 50-79 years is associated with non-vertebral osteoporotic fracture during 15 years follow-up: The Tromso Study 1994-1995.
    Osteoporos Int. 2019 Oct 25. pii: 10.1007/s00198-019-05191.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: